Lupin gets USFDA approval of sNDA for SOLOSEC (secnidazole) to treat trichomoniasis EP News Bureau Jul 1, 2021 SOLOSEC demonstrated a 92.2 per cent clinically and statistically significant cure rate for patients with trichomoniasis based on…
